Which statement about in vitro models used to predict in vivo absorption is most accurate?

Which statement about in vitro models used to predict in vivo absorption is most accurate?

• A. They perfectly predict human intestinal absorption.
• B. They cannot be used to assess permeability at all.
• C. They may not account for in vivo factors such as active transport differences.
• D. They provide exact quantitative estimates of human bioavailability.

Answer: (C)

In vitro models are simplified systems used to estimate how well a drug crosses the intestinal barrier, providing useful permeability data and helping to compare compounds. They give insight into whether a compound can pass through the gut lining and whether transporters might influence this passage, but they don’t capture all the complexities of absorption in a living person. A key limitation is that transporter activity can differ between the in vitro setup and the human intestine, so active transport differences observed in vivo may not be accurately reflected. Additionally, factors like regional differences in transporter expression along the GI tract, metabolism within enterocytes, dissolution and formulation behavior in the gut, gastric emptying, intestinal flow, mucus, and bile salts all influence absorption and are not fully replicated in vitro. Because of these gaps, in vitro models can indicate permeability trends but do not provide exact predictions of in vivo absorption or bioavailability. Therefore, the statement that they may not account for in vivo factors such as active transport differences is the most accurate.

In vitro models are simplified systems used to estimate how well a drug crosses the intestinal barrier, providing useful permeability data and helping to compare compounds. They give insight into whether a compound can pass through the gut lining and whether transporters might influence this passage, but they don’t capture all the complexities of absorption in a living person. A key limitation is that transporter activity can differ between the in vitro setup and the human intestine, so active transport differences observed in vivo may not be accurately reflected. Additionally, factors like regional differences in transporter expression along the GI tract, metabolism within enterocytes, dissolution and formulation behavior in the gut, gastric emptying, intestinal flow, mucus, and bile salts all influence absorption and are not fully replicated in vitro. Because of these gaps, in vitro models can indicate permeability trends but do not provide exact predictions of in vivo absorption or bioavailability. Therefore, the statement that they may not account for in vivo factors such as active transport differences is the most accurate.